Story perspectives

Visa to Buy BioCatch for $2.4 B to Boost Fraud Defense

8/4/2026

Summary

Visa Acquires BioCatch

Visa announced it will acquire Israeli fraud-prevention firm BioCatch for $2.4 billion in cash.
The transaction, funded by Permira and other shareholders, needs regulatory clearance and must close by the end of Visa’s fiscal Q2 2027.
Visa President of Value-Added Services Andrew Torre said BioCatch’s behavioral-biometrics will enable clients to stop fraud before payments.
CEO Gadi Mazor said BioCatch will stay a standalone unit within Visa, keeping its leadership team unchanged.

Summary

Visa Expands Security

Visa has spent $13 billion on security technology and acquired fraud-detection firm Featurespace in December 2024.
Visa’s 2026 threat report flagged nearly $1 billion in scam activity from July through December 2025, its largest fraud category.
A June 2026 survey of 1,440 fraud leaders found 88 % say AI has heightened fraud sophistication and 76 % report fraud-loss increases.
The acquisition expands Visa’s services unit, which sells security, risk, data and analytics tools to banks and merchants.

Summary

Visa Buys BioCatch

Visa announced a $2.4 billion BioCatch acquisition.
Visa held $13.9 billion in cash and securities on June 30 2026, enough to fund the deal internally.
Visa’s shares rose about 2% right after the announcement.
A Thales study in late April said AI-driven bot attacks rose 12.5-fold in 2025, with bots making up over half of internet traffic and 40% malicious.

History

Historical Context

In 1994 William S. McKiernan founded CyberSource, which grew to process roughly 25% of U.S. e-commerce dollars by the time Visa announced its acquisition in April 2010, completing the deal on July 21, 2010. The purchase gave Visa a fraud-detection platform that it has expanded with later buys, including the 2024 acquisition of biometric-security firm BioCatch.

1 of 4

Visa Acquires BioCatch

Visa announced it will acquire Israeli fraud-prevention firm BioCatch for $2.4 billion in cash.
The transaction, funded by Permira and other shareholders, needs regulatory clearance and must close by the end of Visa’s fiscal Q2 2027.
Visa President of Value-Added Services Andrew Torre said BioCatch’s behavioral-biometrics will enable clients to stop fraud before payments.
CEO Gadi Mazor said BioCatch will stay a standalone unit within Visa, keeping its leadership team unchanged.

1 / 4